Envista (NVST)
(Delayed Data from NYSE)
$18.53 USD
-0.60 (-3.14%)
Updated May 17, 2024 04:00 PM ET
After-Market: $18.52 -0.01 (-0.05%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth C Momentum C VGM
Brokerage Reports
Envista Holdings Corporation [NVST]
Reports for Purchase
Showing records 1 - 17 ( 17 total )
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Optimized Entry and Exit Levels for NVST 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
|